Skip to content
OpenCapital
Get started

Avantor AVTR Third-party — Net Sales

Other product segments

Proprietary
$833.3M+0.4%

Similar metrics at other companies

Mirum Pharmaceuticals, Inc. logo
MIRMProduct sales, net — Product sales, net
$159.88M+43.3%
Federal Signal logo
FSSOther — Net Sales
$12M+12.1%
Garrett Motion Inc. logo
GTXOther — Net Sales
$15M+7.1%
Neurocrine Biosciences logo
NBIXNet product sales — Total revenues
$811M+43.9%
Incyte logo
INCYNet sales — Total revenues
$1.1B+19.8%
Home Depot logo
HDOther — Net Sales
$4B+55.8%

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S1×-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's third-party — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's third-party — net sales?
Avantor (AVTR) reported third-party — net sales of $748.1M in Q1 2026.
How has Avantor's third-party — net sales changed year-over-year?
Avantor's third-party — net sales decreased by 0.5% year-over-year, from $751.7M to $748.1M.
What is the long-term trend for Avantor's third-party — net sales?
Over 4 years (2021 to 2025), Avantor's third-party — net sales has grown at a 1.7% compound annual growth rate (CAGR), from $2.91B to $3.1B.
What does third-party — net sales mean?
This metric represents the total revenue generated from the sale of third-party materials, consumables, and related products distributed by the company. It reflects the firm's role as a value-added distributor and supply chain partner for external manufacturers within the biopharma, healthcare, and advanced technology sectors. Monitoring this figure helps investors assess the company's ability to leverage its distribution network and maintain market share in the resale of non-proprietary goods.